Citation Tools

Download PDFPDF
Original article
High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention

Download to a citation manager

Cite this article as:
Breet NJ, van Werkum JW, Bouman HJ, et al
High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention